Quarterly report pursuant to Section 13 or 15(d)

OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)

v3.21.2
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
6 Months Ended
Jun. 30, 2021
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table presents information related to stock options at June 30, 2021:

 

Options Outstanding

   

Options Exercisable

 
               

Weighted

         
               

Average

   

Exercisable

 

Exercise

   

Number of

   

Remaining Life

   

Number of

 

Price

   

Options

   

In Years

   

Options

 

$

2.51-5.00

     

2,447,257

     

7.2

     

1,545,675

 
 

5.01-7.50

     

1,289,032

     

5.9

     

1,013,760

 
 

7.51-10.00

     

203,333

     

8.2

     

115,133

 
 

10.01-12.50

     

65,000

     

8.9

     

48,332

 
         

4,004,622

     

6.9

     

2,722,900

 

 

Options Outstanding

   

Options Exercisable

 
               

Weighted

         
               

Average

   

Exercisable

 

Exercise

   

Number of

   

Remaining Life

   

Number of

 

Price

   

Options

   

In Years

   

Options

 

$

5.00

     

675,000

     

8.17

     

616,665

 

 

Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the Plan for the six months ended June 30, 2021 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at December 31, 2020

   

3,568,497

   

$

5.59

     

7.0

   

$

110,961

 

Grants

   

754,500

     

4.14

     

10.0

   

$

-

 

Exercised

   

(9,375

)

 

$

2.96

             

-

 

Forfeited/expired

   

(309,000

)

 

$

7.23

             

-

 

Outstanding at June 30, 2021

   

4,004,622

   

$

5.20

     

6.9

   

$

190,635

 

Exercisable at June 30, 2021

   

2,722,900

   

$

5.35

     

5.8

   

$

66,322

 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following assumptions were used in determining the fair value of options during the six months ended June 30, 2021:

 

Risk-free interest rate

   

0.83% - 1.30

%

Dividend yield

   

0

%

Stock price volatility

   

89.23% to 95.98

%

Expected life

 

6 years

 

Weighted average grant date fair value

 

$

3.63

 

 

Risk-free interest rate

   

0.05% - 0.25

%

Dividend yield

   

0

%

Stock price volatility

   

88.57

%

Expected life

 

0.25– 2 years

 

 

Risk-free interest rate

   

0.06% - 0.46

%

Dividend yield

   

0

%

Stock price volatility

   

88.59

%

Expected life

 

0.59– 3 years

 

 

Risk-free interest rate

   

0.07% - 0.46

%

Dividend yield

   

0

%

Stock price volatility

   

88.59

%

Expected life

 

1.25- 3 years

 

 

Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block] The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at June 30, 2021:

Exercise

   

Number

 

Expiration

Price

   

Outstanding

 

Date

$

4.80

     

125,000

 

February 2025

$

6.16

     

568,910

 

November 2027

$

6.85

     

193,352

 

July 2021 to August 2021

         

887,262

   

 

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of the warrant activity for the six months ended June 30, 2021 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

Contractual

   

Aggregate

 
   

Shares

   

Exercise Price

   

Term

   

Intrinsic Value

 

Outstanding at December 31, 2020

    1,446,200     $ 5.44       3.3     $ 1,500  

Grants

    -                          

Exercised

    -                          

Expired

    (558,938

)

  $ 4.36       -       -  

Outstanding at June 30, 2021

    887,262     $ 6.12       4.6     $ -  
                                 

Vested and expected to vest at June 30, 2021

    887,262     $ 6.12       4.6     $ -  

Exercisable at June 30, 2021

    887,262     $ 6.12       4.6     $ -  

 

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes the restricted stock activity for the six months ended June 30, 2021:

 

Restricted shares issued as of December 31, 2020

    218,334  

Granted

    251,000  

Vested and issued

    (77,084

)

Forfeited

    (100,000

)

Total

    292,250  

Comprised of:

       

Vested restricted shares as of June 30, 2021

    50,000  

Unvested restricted shares as of June 30, 2021

    242,250  

Total

    292,250  

 

Restricted shares issued as of December 31, 2020

    1,420,716  

Granted

    -  

Issued

    (40,000

)

Forfeited

    (82,716

)

Total

    1,298,000  

Comprised of:

       

Vested restricted shares as of June 30, 2021

    818,000  

Unvested restricted shares as of June 30, 2021

    480,000  

Total

    1,298,000  

 

Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block]

The following table presents information related to warrants (ViralClear) at June 30, 2021:

 

Exercise

   

Number

 

Expiration

Price

   

Outstanding

 

Date

$

5.00

     

473,772

 

November 2027

 

10.00

     

6,575

 

May 2025

         

480,347

   

 

Viral Clear [Member]  
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the ViralClear Plan for the six months ended June 30, 2021 is as follows:

 

                   

Weighted-Average

 
           

Weighted-Average

   

Remaining

Contractual

 
   

Shares

   

Exercise Price

   

Term

 

Outstanding at December 31, 2020

    1,527,666     $ 5.00       3.96  

Grants

    -                  

Exercised

    -                  

Forfeited/expired

    (852,666

)

  $ 5.00          

Outstanding at June 30, 2021

    675,000     $ 5.00       8.17  

Exercisable at June 30, 2021

    616,665     $ 5.00       8.11